American Renal Associates Holdings Inc (ARA) Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its stake in American Renal Associates Holdings Inc (NYSE:ARA) by 1.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 691,555 shares of the company’s stock after buying an additional 12,549 shares during the period. JPMorgan Chase & Co. owned about 2.13% of American Renal Associates worth $14,972,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Bank of New York Mellon Corp increased its holdings in shares of American Renal Associates by 11.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 52,733 shares of the company’s stock worth $831,000 after buying an additional 5,478 shares during the last quarter. Macquarie Group Ltd. increased its holdings in shares of American Renal Associates by 1,867.7% in the 2nd quarter. Macquarie Group Ltd. now owns 20,700 shares of the company’s stock worth $326,000 after buying an additional 19,648 shares during the last quarter. Renaissance Technologies LLC increased its holdings in shares of American Renal Associates by 111.2% in the 2nd quarter. Renaissance Technologies LLC now owns 347,500 shares of the company’s stock worth $5,480,000 after buying an additional 183,000 shares during the last quarter. Adams Diversified Equity Fund Inc. bought a new position in shares of American Renal Associates during the 3rd quarter valued at $559,000. Finally, Schwab Charles Investment Management Inc. grew its holdings in shares of American Renal Associates by 28.2% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 71,327 shares of the company’s stock valued at $1,125,000 after purchasing an additional 15,675 shares during the last quarter. 94.51% of the stock is currently owned by hedge funds and other institutional investors.

ARA stock opened at $16.03 on Friday. The company has a debt-to-equity ratio of 5.48, a quick ratio of 1.00 and a current ratio of 1.03. American Renal Associates Holdings Inc has a 52 week low of $13.91 and a 52 week high of $24.07. The firm has a market cap of $534.26 million, a P/E ratio of 24.16, a price-to-earnings-growth ratio of 4.47 and a beta of 2.01.



American Renal Associates (NYSE:ARA) last released its earnings results on Thursday, November 8th. The company reported $0.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.13 by $0.06. American Renal Associates had a negative net margin of 1.81% and a positive return on equity of 22.30%. The company had revenue of $211.02 million for the quarter, compared to analyst estimates of $217.15 million. During the same quarter last year, the firm earned $0.19 EPS. The firm’s quarterly revenue was up 12.4% compared to the same quarter last year. Research analysts expect that American Renal Associates Holdings Inc will post 0.58 earnings per share for the current year.

Several equities analysts recently commented on ARA shares. SunTrust Banks reaffirmed a “buy” rating and set a $25.00 target price on shares of American Renal Associates in a report on Thursday, August 9th. Zacks Investment Research raised shares of American Renal Associates from a “sell” rating to a “hold” rating in a report on Thursday, August 9th. Leerink Swann raised shares of American Renal Associates from a “market perform” rating to an “outperform” rating and increased their target price for the company from $22.00 to $26.00 in a report on Thursday, August 23rd. Finally, Bank of America increased their target price on shares of American Renal Associates from $21.00 to $24.00 and gave the company a “buy” rating in a report on Tuesday, September 18th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. American Renal Associates currently has an average rating of “Buy” and an average price target of $22.60.

ILLEGAL ACTIVITY NOTICE: This story was first reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://dakotafinancialnews.com/2018/12/07/american-renal-associates-holdings-inc-ara-shares-bought-by-jpmorgan-chase-co.html.

American Renal Associates Profile

American Renal Associates Holdings, Inc operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease.

Featured Article: What are trading strategies for the 52-week high/low?

Want to see what other hedge funds are holding ARA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Renal Associates Holdings Inc (NYSE:ARA).

Institutional Ownership by Quarter for American Renal Associates (NYSE:ARA)

Receive News & Ratings for American Renal Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply